Sidley Life Sciences Briefing
Recent ESG Developments in Europe
August 2026
Switzerland has consulted on its own environmental, social, and governance (ESG) framework modeled on EU rules, while several EU obligations with direct relevance to pharmaceutical and medical device companies take effect in the coming months. This article summarizes the key developments and the steps companies should be taking now.
Offices
関連公式ブログ
得意分野
Suggested News & Insights
CARB Workshop Gives Glimpse of Possible Future for SB 253 ReportingJuly 27, 2026EU Forced Labor Regulation Moves Toward Implementation: How Companies Should PrepareJuly 7, 2026Sidley Top-Ranked in Chambers Crisis & Risk Management 2026June 25, 2026Sidley Advises on Genting Group’s Landmark US$1.25 Billion Perpetual Securities Issuance and Concurrent US$1.5 Billion Tender OfferMay 20, 2026Global ESG and Sustainability Update: Reporting & Due Diligence Developments and Compliance StrategiesTuesday, May 19, 2026Industrial Accelerator Act: A New Framework for EU (Sustainable) Industrial GrowthApril 9, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


